Faculty Profiles

Anne R. Cappola, M.D. Sc.M.
Assistant Professor of Medicine and Epidemiology
Director of Research Programs for FOCUS on Health and Leadership for Women

 

Dr. Cappola's Research

Business Address

 

Division of Endocrinology, Diabetes, and Metabolism
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania School of Medicine
718 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Phone: (215) 573-5359
Fax: (215) 573-5325
E-mail:
acappola@cceb.med.upenn.edu

Education

Undergraduate: Harvard University
Degree: A.B. in Biochemistry

Medical: University of Pennsylvania
Degree: M.D.

Johns Hopkins Bloomberg School of Public Health
Degree: Sc.M. in Clinical Epidemiology

Residency

Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

Fellowship:
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Johns Hopkins Hospital
Baltimore, Maryland

Board Certification:
Internal Medicine
Endocrinology, Diabetes & Metabolism

Biography

Anne R. Cappola, M.D., Sc.M. is an Assistant Professor of Medicine and Epidemiology and a Senior Scholar at the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. Dr. Cappola received her A.B. in Biochemistry at Harvard University and her M.D. at the University of Pennsylvania. She was a resident in Medicine at the Brigham and Women’s Hospital and a fellow in Endocrinology at the Massachusetts General Hospital in Boston and at the Johns Hopkins Hospital in Baltimore. She has also completed a Master of Science in Clinical Epidemiology and a fellowship in the Epidemiology of Aging at the Johns Hopkins Bloomberg School of Public Health. Dr. Cappola was an Assistant Professor at the University of Maryland from 2001-2002, joining the Penn faculty in 2003.

Dr. Cappola’s research focuses on the hormonal alterations that occur with aging and the clinical impact of these changes, particularly in older women. Her work on the roles of hormonal and inflammatory markers in disability and frailty suggests that IGF-1 and IL-6 may be important joint targets for treatments to prevent or minimize disability associated with aging. Ongoing projects include analyses of the relationship between levels of androgens and muscle loss in older women; of the combined effects of endocrine, inflammatory, and nutritional factors as risk factors for the frailty syndrome; and of the association between thyroid dysfunction and cardiovascular disease in older men and women.

Faculty Research Index